San Francisco, California, United States Emerging Technology Partners is the famous VC, which was founded in 2000. The fund was located in North America if to be more exact in United States. The main department of described VC is located in the San Francisco.
The fund was created by Wei-Wu He. Besides them, we counted 1 critical employee of this fund in our database.
The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 10 percentage points more often commits exit comparing to other organizations. Comparing to the other companies, this Emerging Technology Partners performs on 31 percentage points more the average number of lead investments. The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2015.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Emerging Technology Partners, startups are often financed by Solstice Capital, Village Ventures, Valley Ventures. The meaningful sponsors for the fund in investment in the same round are OrbiMed, MPM Capital, Alta Partners. In the next rounds fund is usually obtained by TPG, InterWest Partners, Alta Partners.
Among the most successful fund investment fields, there are Biotechnology, Genetics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight CASI Pharmaceuticals, Polaris Biology, Intradigm Corporation. The fund has exact preference in a number of founders of portfolio startups.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Baker Brothers Advisors LLC | New York, New York, United States |
| Crescent Enterprises Venture Capital | Sharjah, Sharjah Emirate, United Arab Emirates |
| Forbes Family Trust | New York, New York, United States |
| Global Millennial Capital | Dubai, United Arab Emirates |
| Granger Management LLC | - |
| Janchor Partners | China, Hong Kong, Hong Kong Island |
| Liangcang Accelerator | China, Hangzhou, Zhejiang |
| Panthera Capital Ventures | Dubai, United Arab Emirates |
| Rongyin Capital | Beijing, China, Haidian |
| Shanghai Houting Management Consulting | China, Shanghai |
| Shibuya Kogyo | Ishikawa Prefecture, Japan, Kanazawa |
| Strategic Equities | - |
| The Eleos Foundation | California, Santa Barbara, United States |
| TIM | Italy, Lazio, Roma |
| Topfonds Gelderland | - |
| V8 Capital Partners | Ebène, Mauritius, Plaines Wilhems |
| Venvest Capital | California, Santa Monica, United States |
| Vilitas GmbH & Co. KG | Aachen, Germany, Nordrhein-Westfalen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Human Longevity | $39M | 21 Aug 2024 | San Diego, California, United States | ||
Heranova Lifesciences | $3M | 28 Dec 2023 | Huangpu, Shanghai, China | ||
Polaris Biology | $10M | 24 Jun 2020 | Shanghai, China | ||
Human Longevity | $30M | 07 Nov 2019 | San Diego, California, United States | ||
Polaris Biology | $8M | 21 Jan 2019 | Shanghai, China | ||
DoctorsForMe Inc | $1M | 23 Mar 2018 | South San Francisco, California, United States | ||
TCR Cure | 01 Jun 2017 | Nansha District, Guangdong Province, China | |||
Intradigm Corporation | $16M | 21 Nov 2006 | Palo Alto, California, United States | ||
HTG Molecular Diagnostics | $3M | 19 Oct 2005 | Tucson, Arizona, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Human Longevity | $39M | 21 Aug 2024 | San Diego, California, United States | ||
Heranova Lifesciences | $3M | 28 Dec 2023 | Huangpu, Shanghai, China | ||
Polaris Biology | $10M | 24 Jun 2020 | Shanghai, China | ||
Human Longevity | $30M | 07 Nov 2019 | San Diego, California, United States | ||
Polaris Biology | $8M | 21 Jan 2019 | Shanghai, China | ||
DoctorsForMe Inc | $1M | 23 Mar 2018 | South San Francisco, California, United States | ||
TCR Cure | 01 Jun 2017 | Nansha District, Guangdong Province, China | |||
Intradigm Corporation | $16M | 21 Nov 2006 | Palo Alto, California, United States | ||
HTG Molecular Diagnostics | $3M | 19 Oct 2005 | Tucson, Arizona, United States |
